2
Registered trials
2
Recruiting
2
Unique sponsors
1
Unique IMPs
1
Commercial trials
Drug classes (ATC)
N
Neurology/Psychiatry (ATC N)
1
—
ATC code not specified
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
1 substance
Phase II/III:
1
Phase IV:
1
Phase II/III
1 trial-
RecruitingExelixis Inc. CommercialN-(4-FLUOROPHENYL)-N-(4-((7-METHOXY-6-(METHYLCARBAMOYL)QUINOLIN-4- YL)OXY)PHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE
Phase IV
1 trial-
RecruitingAntwerp University Hospital AcademicIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Exelixis Inc. | Commercial | 1 | Phase II/III | 1 |
| Antwerp University Hospital | Academic | 1 | Phase IV | 1 |
New trials by year
2023
1
2026
1